Envarsus XR 1 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DX25F6SHS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $2,148
Award facts
- Contract value 100% obligated
- $2,148.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Envarsus XR 1 mg tablets (100-count packaging). This firm fixed price delivery order, valued at $2,148.10, is scheduled for completion by August 18, 2025, and represents a non-set-aside, competitively awarded contract. The delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
This award reflects AmerisourceBergen's established role as a critical federal pharmaceutical vendor, supplying medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Envarsus XR is a tacrolimus-based immunosuppressant medication typically used in transplant and immunological applications, underscoring the company's capability to deliver specialized pharmaceutical products to federal medical procurement needs. The contract's firm fixed pricing structure and rapid completion timeline are consistent with AmerisourceBergen's demonstrated versatility in fulfilling federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DX25F6SHS?
SPE2DX25F6SHS was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on July 28, 2025.
How much is contract SPE2DX25F6SHS worth?
The government has obligated $2,148 on SPE2DX25F6SHS.
Is contract SPE2DX25F6SHS an order under another contract?
Yes. SPE2DX25F6SHS is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6SHS competed?
The extent of competition for SPE2DX25F6SHS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award